Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.

Abstract

Multiparametric flow cytometry of MRD in ALL patients is a valuable tool for relapse prediction and for the identification of a cohort of patients with very poor prognosis.